AIMEDBIO
IR
ENG
KOR
ABOUT US
Overview
Leadership
Corporate Governance
R&D
AimedBio’s Drug Development
P-ADC™
Pipeline
IR
Disclosure
Stock
Financial Information
PR
Notice
Press Release
Data Room
CAREERS
Our Culture
Recruitment Process
Job Opportunities
Disclosure
54 posts
NO.
Title
Date
Author
24
Material Management Information related to Judgment of Investment (AMB303 공동개발 및 라이선스 계약 관련 옵션행사 기술료 수령)
2025-12-26
에임드바이오
23
Report on significant holdings of stocks, etc. (Short form)
2025-12-22
에스엠비투자파트너스
22
Closure of Register of Shareholders or Designation of Record Date
2025-12-15
에임드바이오
21
[Corrected description]Report on significant holdings of stocks, etc. (Short form)
2025-12-11
디에스자산운용
20
Report on significant holdings of stocks, etc. (Short form)
2025-12-11
디에스자산운용
19
Report on status of specific securities, etc. owned by executives and major shareholders
2025-12-10
남도현
18
Report on significant holdings of stocks, etc. (General)
2025-12-10
남도현
17
Quarterly Report (2025.09)
2025-12-10
에임드바이오
16
Report on status of specific securities, etc. owned by executives and major shareholders
2025-12-09
인터베스트
15
Report on significant holdings of stocks, etc. (Short form)
2025-12-09
인터베스트
Material Management Information related to Judgment of Investment (AMB303 공동개발 및 라이선스 계약 관련 옵션행사 기술료 수령)
에임드바이오
2025-12-26
Report on significant holdings of stocks, etc. (Short form)
에스엠비투자파트너스
2025-12-22
Closure of Register of Shareholders or Designation of Record Date
에임드바이오
2025-12-15
[Corrected description]Report on significant holdings of stocks, etc. (Short form)
디에스자산운용
2025-12-11
Report on significant holdings of stocks, etc. (Short form)
디에스자산운용
2025-12-11
Report on status of specific securities, etc. owned by executives and major shareholders
남도현
2025-12-10
Report on significant holdings of stocks, etc. (General)
남도현
2025-12-10
Quarterly Report (2025.09)
에임드바이오
2025-12-10
Report on status of specific securities, etc. owned by executives and major shareholders
인터베스트
2025-12-09
Report on significant holdings of stocks, etc. (Short form)
인터베스트
2025-12-09
1
2
3
4
5